Inspira Technologies Establishes U.S. Distribution Facility
Ticker: IINNW · Form: 6-K · Filed: Oct 24, 2024 · CIK: 1837493
Sentiment: neutral
Topics: distribution, deployment, medical device
TL;DR
Inspira sets up US distribution for ART100 device, boosting market access.
AI Summary
On October 24, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced the establishment of a distribution facility to support the U.S. deployment of its INSPIRA ART100 device. This move is intended to streamline logistics and enhance customer service for their innovative respiratory support technology in the United States.
Why It Matters
This facility aims to improve the accessibility and support for Inspira's ART100 device in the crucial U.S. market, potentially accelerating adoption and revenue growth.
Risk Assessment
Risk Level: low — This filing is an informational report of a press release and does not contain new financial data or significant operational changes that would inherently increase risk.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- INSPIRA ART100 (product) — Device being deployed
- October 24, 2024 (date) — Date of press release
FAQ
What is the primary purpose of the newly established distribution facility?
The primary purpose is to support the U.S. deployment of the INSPIRA ART100 device by streamlining logistics and enhancing customer service.
When was the press release announcing this facility issued?
The press release was issued on October 24, 2024.
What specific product will the distribution facility support?
The distribution facility will support the INSPIRA ART100 device.
Which company issued this report on Form 6-K?
Inspira Technologies Oxy B.H.N. Ltd. issued this report.
What type of filing is this report?
This report is a Form 6-K, a report of a foreign private issuer.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-10-24 16:01:22
Filing Documents
- ea0218523-6k_inspira.htm (6-K) — 17KB
- ea021852301ex99-1_inspira.htm (EX-99.1) — 13KB
- 0001213900-24-090369.txt ( ) — 31KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: October 24, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2